Research News & Publications

International collaboration yields insights into childhood leukemia risk

11/25/2019

Researchers know that different biology underlies CLL and ALL. However, there may be a link between the two diseases.
St. Jude researchers among the most highly cited in 2019

11/22/2019

Nearly 20 scientists from St. Jude Children's Research Hospital named Highly Cited Researchers for 2019 by the Web of Science group.
Gene therapy for X-linked SCID wins 2019 Smithsonian Magazine American Ingenuity Award

11/19/2019

Gene therapy developed by the late Brian Sorrentino honored by Smithsonian Magazine.
Understanding transporter proteins at a single-molecule level

11/13/2019

Research co-led by a St. Jude investigator and researchers from Columbia University and the New York State Psychiatric Institute reveals the mechanics of how some transporter proteins function with stunning specificity.
Chemotherapy sometimes sets the stage for drug-resistant leukemia at relapse

11/01/2019

An International collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia who relapse.
Treating the TOTAL patient: clinical trial reduces relapse

10/28/2019

Researchers at St. Jude have announced results of the Total Therapy Study 16 clinical trial, which tested strategies for lowering the rate of relapse of acute lymphoblastic leukemia in children from 2007–2017.
Controlling the immune system’s brakes to treat cancer, autoimmune disorders

10/24/2019

St. Jude researchers have discovered two enzymes that may have a crucial role in treating autoimmune disorders and certain cancers.
Exercise may give the brain a boost

10/21/2019

A St. Jude study reveals more about the link between cancer survivors’ physical fitness and their thinking and learning skills.
Childhood cancer survivorship data portal in St. Jude Cloud launched at ASHG

10/18/2019

A St. Jude Children’s Research Hospital online portal into pediatric cancer survivorship data debuts at the American Society of Human Genetics annual meeting.
Pharmacogenetics of thiopurine and NUDT15 mutations presented at ASHG

10/18/2019

Researchers have uncovered a relationship between the gene NUDT15 and how thiopurine drugs function. These findings support the use of NUDT15 to guide thiopurine dose to limit treatment related toxicity.